Alzprotect: AlzProtect: The American FDA Has Granted AZP2006 the Orphan Drug Designation for the Treatment of Progressive Supranuclear Palsy (PSP)

Alzprotect is a France-based biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases.